my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
in.vent Clinical Services (ICS) is a holistic service provider for diagnostic studies and IVD validation. ICS was founded with regard to the EU in-vitro diagnostics regulation (IVDR). This law strongly increases the complexity of the IVD validation process and demands a re-validation of already CE more
GKM (Gesellschaft für Therapieforschung mbH) is an independent, family-owned contract research organization (CRO). GKM provides a comprehensive portfolio of CRO services for the pharmaceutical industry, manufacturers of medical devices and academia. Founded in 1981, GKM is headquartered in Munich, more
Sciomics GmbH was founded in the spring of 2013 as a spin-off company of the German Cancer Research Center (DKFZ) by Dr. Christoph Schröder and Dr. Jörg Hoheisel. Since 2003, our team has gained experience with production and application of antibody microarrays as a tool for analysing complex protei more
Advanced genomics testing for analytics and quality control of therapeutic products ✓ cGMP storage facilities for ancillary materials, retained collections and safety studies ✓ Cryogenic automation and digital inventory systems to enable a streamlined scale-up process ✓ more
Cambridge scientists have identified 200 approved drugs predicted to work against COVID-19 - of which only 40 are currently being tested in COVID-19 clinical trials. In a study published today in Science Advances, a team led by researchers at the University of Cambridge's Milner Therapeutics Institu more
In the treatment of SARS-CoV-2, the virus that causes COVID-19, antiviral drug remdesivir has emerged as a promising candidate. Remdesivir works by disrupting the virus's ability to replicate, but its exact mechanism has remained a mystery. Using advanced computational simulations, researchers at th more
APEIRON Biologics AG announced the launch of a Pilot investigator-initiated clinical trial (IIT) with APN01, a recombinant human angiotensin-converting enzyme 2 (rhACE2), to treat patients with severe coronavirus infection in the People's Republic of China. The randomized, unblinded trial will treat more
Case studies on ultra sensitive bioanalysis of biologics with challenging molecular characteristics and the need for broad assay range are discussed. more
Biomarkers are currently changing the way we diagnose and treat diseases. Today pharmacodynamic biomarkers are widely used in the industry elaborating optimal dosing of new drugs and predictive biomarkers have an enormous potential for companion diag more
As a consumer, it’s easy to be oblivious to the amount of time, work, and money that goes into the development of a drug. The cost of developing a drug that goes on to gain marketing approval was estimated to be $2,558 million in 2014, and the process can commonly last longer than a decade. Addition more
Today’s graphic looks at science in general, rather than just chemistry. It’s in a similar vein to the Rough Guide to Spotting Bad Science posted last year, but this time looking at the hierarchy of different types of scientific evidence. You might think science is science, but some evidence is rank more
We would like to fill the following vacancy as soon as possible: Clinical Trial Associate (f/m/d) Your Role: Organise, maintain and complete the paper and electronic trial master files Identify, request and ensure delivery of outstanding and outdated documents Periodically, and at the more
Viruses, Vol. 10, Pages 351: Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy Viruses doi: 10.3390/v10070351 Authors: Frank Oechslin Bacteriophage (phage) therapy, i.e., the use of viruses that infect bacteria as antimicrobial agents, is a promising alte more
In the fight against antibiotic-resistant infections, a decades-old approach based on bacteria-slaying viruses called phages has been sidelined by technical hurdles, dogged by regulatory confusion, and largely ignored by drug developers in the West. But 2 years ago, researchers at the University of more
Antibiotic development is frequently plagued by the rapid emergence of drug resistance. However, assessing the risk of resistance development in the preclinical stage is difficult. By building on multiplex automated genome engineering, we developed a method that enables precise mutagenesis of multip more
AIDS Clinical Trials Group The AIDS Clinical Trials Group (ACTG) is the largest HIV clinical trials organization in the world, playing a major role in setting standards of care for HIV infection and opportunistic diseases related to HIV and AID ... more
Watchlist
This is where you can add this topic to your personal favourites
© 1997-2022 LUMITOS AG, All rights reserved
